OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Alzheimers Disease is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	159
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	129
Hydrate to keep the amyloid away	107
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	90
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	86
Dementia in Denmark: Uncovering the causes of death and life years lost in a nationwide, register-based cohort study	75
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques	72
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	68
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	68
Soda consumption and risk of dementia: The Northern Manhattan study	63
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link for early detection	63
Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital	63
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning	62
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	62
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	61
Blood pressure dynamic instability and neurodegeneration in older adults	60
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies	55
Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach	53
Patterns of cortical atrophy are associated with specific cognitive domains in patients with logopenic primary progressive aphasia	52
Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease	51
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	50
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	49
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	49
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	48
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	47

Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	46
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	45
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	45
Incident Dementia After Spontaneous Intracerebral Hemorrhage	45
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	44
Attentional Control in Subjective Cognitive Decline	42
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	42
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	41
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	41
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	40
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	38
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	38
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	37
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	36
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	36
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	36
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	35
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	35
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	34
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	34
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	34
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	34
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	34
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	34
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	33
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	33
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	33
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	33
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	33
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	33
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	32
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	32
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	32
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	32
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	32
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	31
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	31
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	31
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	30
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	30
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	30
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	30
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	30
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	30
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	30
The association between hemoglobin level and risk of developing dementia	30
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	29
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	29
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease	29
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	29

Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	29
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	29
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	29
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review	29
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	28
From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation	28
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum	28
Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view	28
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	27
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	27
Choroid plexus–glymphatic axis disruption in Alzheimer's disease: Cerebrospinal fluid expansion as a mediator of metabolic dysfunction and cognitive decline	27
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	27
HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians: Cohort profile, progress, current contributions, and future impact	27
Decoding the key mechanisms of ferroptosis and inflammation: Emerging therapeutic targets for Alzheimer's disease	27
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	27
Altered temporal dynamics of intrinsic brain activity in mild cognitive impairment with olfactory dysfunction	27
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	26
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	26
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	26
Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment	26
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	25
Hospitalizations and long-term care for older adults with Alzheimer's disease and related dementia: Differences across geographic regions of the United States	25
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	25
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	25
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	25
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	25
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	25
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	25
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	24
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	24
Societal Costs of Dementia: 204 Countries, 2000–2019	24
Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disea	24
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	24
Ketogenic diet enhances cognitive-behavioral function and hippocampal neurogenesis while attenuating amyloid pathology in Tg-SwDI mice	24
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	24
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	24
Gait and movement analysis for discrimination between people with dementia and healthy control persons based on pose estimation and machine learning	24
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	23
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	23
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	23
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	23
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	23
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	23
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	23
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	23
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	23
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	23
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	23
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	23
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	23
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	22
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	22
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	22
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	22
Evaluation of early-phase ¹⁸ F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with ¹⁸	22
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	22
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	22
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	22
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	22
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	22
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	22
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	22
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	22
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	22
The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review	22
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	22
Antidepressant and anxiolytic medications and risk of mortality in people with dementia: A nested case-control study in Northern Ireland	22
Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	22
Neuropsychiatric signs and symptoms clusters and regional amyloid on ¹⁸ F-FC119S PET in Alzheimer's disease	21
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	21
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	21
Mites, microbes, and neurodegeneration: A unified environmental hypothesis for Parkinson's disease, Alzheimer's disease, and Lewy body dementia	21
Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China	21
Distinct brain atrophy patterns in Lewy body disease: The impact and interaction of comorbid neuropathologies revealed by voxel-based morphometry	21
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	21
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	21
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	21
Phosphorylated peptide Tau-pT181 induced tau aggregation and cognitive dysfunction	21
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	21
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	21

Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	21
Perceived everyday discrimination and its effect on cognitive function through depression in diverse populations: A HABS-HD study	21
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	21
Impact of coronary interventions on dementia diagnosis by race: Insights from a multi-hospital heart-brain registry	20
COVID-19 and Alzheimer’s Disease: What Is the Connection?	20
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	20
Meaning in life and neurobiomarkers of brain health in the UK Biobank	20
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	20
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	20
Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States	20
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	20
Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging study	20
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	20
Helicobacter pylori and Alzheimer's disease risk: The HUNT study	20
GAPDH citrullination as a molecular signature of neurodegeneration, assessed in prion diseases	20
The role of carotenoids from red mamey fruit ( Pouteria sapota ) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET pred	19
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	19
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	19
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	19
Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990–2021 in relation to Africa and the world	19
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	19
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	19
Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank	19
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	19
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition	19
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	19
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	19
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	19
The atherogenic index of plasma and triglyceride glucose-body mass index are inversely associated with cognitive impairment in middle-aged and older Chinese adults: A community-based cohort study	19
Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer’s Disease	19
Hearing loss, plasma neurodegenerative biomarkers, and cognitive function: Independent and additive effects	19
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	19
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	19
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloi	19
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	19
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers	19
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	19
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain	19
Environmental risk and genetic susceptibility in Alzheimer's disease: Impacts on cognitive function and biomarkers	19
Distinct patterns of microstructural brain changes in Alzheimer's disease subtypes: Diffusion MRI metrics in braak stage-related regions	19
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	19
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	19
Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights	18
The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China	18
Hippocampal transcriptome-wide association analysis of shared genetic risks between posttraumatic stress disorder and Alzheimer's disease	18
Repetitive transcranial magnetic stimulation enhances alpha power in Alzheimer's disease patients	18
Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration	18
Causal Association Between mTOR-Dependent Protein Levels and Alzheimer’s Disease: A Mendelian Randomization Study	18
Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults	18
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	18
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	18
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	18
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation	18
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	18
Loneliness, Dementia Status, and Their Association with All-Cause Mortality Among Older US Adults	18
Uncovering polygenic and local genetic overlap between sarcopenia and Alzheimer's disease	18
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment	18
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers	18
PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease	18
The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease	18
Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life	18
Sex Differences in Dementia, Cognition, and Health in the Cognitive Function and Ageing Studies (CFAS)	18
Corrigendum to “The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China”	17
Written picture descriptions distinguish variants of primary progressive aphasia	17
Concerning the debate about homocysteine, B vitamins, and dementia	17
Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1	17
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer’s Disease Pathology	17
How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study	17
Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 mice	17
Mutual effects of sleep duration and traits on the risk of dementia: A prospective study in the UK Biobank	17
Phonological and Semantic Fluency in Alzheimer’s Disease: A Systematic Review and Meta-Analysis	17
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	17
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians’ Judgements for Person-Centered Care: An Analytic Hierarchy Process Study	17
Sex differences in cognitive trajectories and practice effects in a cohort of older Londoners: The role of risk factors	17
A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data	17
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	17
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy	17
Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease	17
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	17
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	17
Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain	17
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	17
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	17
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease	17
Dementia Knowledge, Attitude toward Dementia, and Confidence in Dementia Care: Impact of a Dementia Training on German Nursing Students	17
The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach	17
Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease	17
Systematic review and meta-analysis of associations between neuropsychiatric symptoms and amyloid, tau, neuronal, and glial biomarkers in young-onset dementias	17
Evaluating self- and informant-reported complaints as predictors of cognitive progression in subjective cognitive decline: A clinically-based evaluation	17
Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment	17
Towards characterizing subjective cognitive decline in older adults	17
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	17
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	17
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment	17
Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging	17